OCALA, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (NYSE American: AIM) (“AIM”) today announced the official print publication of the data analysis from a long-term Early Access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback